share_log

博瑞生物医药(苏州)股份有限公司主体及“博瑞转债”2024年度跟踪评级报告

Rating report on Borui Biomedical (Suzhou) Co., Ltd. and the "Borui Convertible Bonds" for the 2024 tracking year.

Sensex a share ·  Jun 22

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.